Report #2841401

Overview

Sex

Unknown

Age

Age unknown

State

CO

Recovered

Unknown

Vaccinated

—

Onset

—

Days to onset

—

Hospital days

—

Symptoms (1)

Symptom narrative

Pediatric dose administered to adult patient; Pediatric dose administered to adult patient; This non-serious case was reported by a other health professional via call center representative and described the occurrence of adult use of a child product in a adult patient who received HBV (Engerix B pediatric) for prophylaxis. On an unknown date, the patient received Engerix B pediatric. On an unknown date, an unknown time after receiving Engerix B pediatric, the patient experienced adult use of a child product (Verbatim: Pediatric dose administered to adult patient) and underdose (Verbatim: Pediatric dose administered to adult patient). The outcome of the adult use of a child product and underdose were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 02-MAY-2025 Other Health Professional reported that he/she administered a pediatric dose of the Engerix-B Hepatitis B to an adult patient, which led to adult use of a child product and underdose. And reporter wants to just trying to see how to advice in if can just administered another dose or if just need to administered an adult dose. No more details were left by reporter in the voicemail.